CN Patent

CN113030283A — 一类雷沙吉兰基因毒性杂质化合物及其制备方法和用途

Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2021-06-25 · 5y expired

What this patent protects

本发明公开了一种式XI，式XII和式XIII所示雷沙吉兰基因毒性杂质化合物，该类化合物制备方法及其在雷沙吉兰中间体和成品质量检查时作为基因毒性杂质对照品的用途，本发明的实施有效的控制了雷沙吉兰的质量，从而保证雷沙吉兰临床使用的安全性和有效性。

USPTO Abstract

本发明公开了一种式XI，式XII和式XIII所示雷沙吉兰基因毒性杂质化合物，该类化合物制备方法及其在雷沙吉兰中间体和成品质量检查时作为基因毒性杂质对照品的用途，本发明的实施有效的控制了雷沙吉兰的质量，从而保证雷沙吉兰临床使用的安全性和有效性。

Drugs covered by this patent

Patent Metadata

Patent number
CN113030283A
Jurisdiction
CN
Classification
—
Expires
2021-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Huahai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.